Anna Beck on Muck Rack

Anna Beck

St. Louis
As seen in: Nature, The Guardian, JAMA Network, Cell Press, The Salt Lake Tribune, Chicago Reader, KSDK-TV (St. Louis, MO), St. Louis Magazine, City Mom Collective, Réussir Agriculture Massif Central and
Passion for art, cooking, fitness & clean living -- Attorney, Writer, Clean Beauty Advocate -- I prefer the road less traveled
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anna

Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer

|
By Zhijie Li, Jeremy T-H. Chang, Andy Tran, Colin Kenny, Terry Braun, Ronald Weigel, Anna Beck, Guillermo M. Ng Yi, Victoria L. Deters
| Nature Verified
Abstract Molecular testing can refine the prediction of cancer recurrence. We sought to compare patterns of gene expression in patients with and without recurrence of well-differentiated thyroid cancer to identify pathways associated with recurrence and develop a predictive model based on gene expression.
Open in Who Shared Issue with article?

Rep. Mike Kennedy is willing to fund machinery that harms people while balking at investments that keep Utahns alive

|
By Anna Beck
| The Salt Lake Tribune Verified
Rep. Mike Kennedy, M.D., has built his political persona on two claims: that extending Affordable Care Act subsidies is "too expensive," and that as a doctor he lives by the oath to "do no harm." Those claims cannot both be true.
Open in Who Shared Issue with article?

Risk Counseling Tools for Contralateral Breast Cancer Risk After Genetic Testing

|
By Anna Beck
| JAMA Network Verified
Increased rates of contralateral prophylactic mastectomies (CPM) have been reported in patients undergoing genetic testing, regardless of the testing result.1 With both expanded access to genetic testing and increasing support for universal genetic testing of all patients with newly diagnosed breast cancer,2,3 an unintended outcome may be continued increases in CPM.
Open in Who Shared Issue with article?
See all 84 licensed articles (100 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified